We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Mobile Diagnostic Imaging App Extends Access to Non-DICOM Data to Image-Enabling any Healthcare Enterprise

By MedImaging International staff writers
Posted on 02 Jun 2014
New mobile diagnostic imaging application (app) software has made it simpler for healthcare enterprises to retrieve and review any patient image, and diagnose from mobile devices in an entirely secure manner.

Calgary Scientific, Inc. (Calgary, Canada) has received US Food and Drug Administration (FDA) clearance for its medical viewing software, ResolutionMD 4.0, for all modalities and Chinese FDA (CFDA) certification for diagnosis on mobile devices in China.

“Mobile solutions can empower caregivers, enhance efficiency and improve patient care, but only if healthcare data remains protected at all times,” said Sid Nair, vice president/general manager for healthcare and life sciences, Dell Services (Plano TX, USA). “With Calgary Scientific’s ResolutionMD 4.0 as part of the cloud-based Dell unified clinical archive, physicians can securely view images and render a diagnosis from any web or mobile device across the enterprise or even outside the walls of the hospital.”

The new version of ResolutionMD enables wider access to critical information in a entirely secure manner by: extending the view of a patient record across disparate systems and geographies by providing additional support for non-Digital Imaging and Communications in Medicine (DICOM) data types; the system adds to the range of reporting systems supported, giving access to the complete patient record that is required to make informed clinical decisions; and provides administrators with better control over how physicians access patient records in an enterprise, increasing security while allowing easy access to pertinent data.

“We are proud to release the latest version of ResolutionMD with better access to patient records, reporting and additional security improvements that contribute to safe, mobile patient care,” said Pierre Lemire, president and CTO of Calgary Scientific. “The release of ResolutionMD 4.0 in combination with our global accreditations, give our partners the leading technology they need to make virtual healthcare an industry standard.”

Diagnostic medical imaging software ResolutionMD, enables clinicians to securely view patient images and reports from a wide variety of computers and mobile devices, collaborate with other practitioners and diagnose from any location. Whether the user is a single facility or a large healthcare system with tens of thousands of users, ResolutionMD is the best choice for seamless image access across multiple departments. The FDA-cleared, CFDA-certified, Health Canada- licensed, and CE marked mobile medical diagnosis software can be incorporated into any electronic medical record (EMR) and easily plugs into existing distributed storage systems.

ResolutionMD’s federated approach is an important differentiator from other solutions, as very sensitive data are never moved to a device and no additional data storage locations are created. ResolutionMD is published in 11 languages and is currently installed in leading healthcare institutions worldwide via a network of more than 45 world class healthcare partners.

Related Links:

Calgary Scientific


New
Mammography System (Analog)
MAM VENUS
Silver Member
X-Ray QA Meter
T3 AD Pro
Portable Color Doppler Ultrasound System
S5000
X-ray Diagnostic System
FDX Visionary-A

Channels

Nuclear Medicine

view channel
Image: The diagnostic tool could improve diagnosis and treatment decisions for patients with chronic lung infections (Photo courtesy of SNMMI)

Novel Bacteria-Specific PET Imaging Approach Detects Hard-To-Diagnose Lung Infections

Mycobacteroides abscessus is a rapidly growing mycobacteria that primarily affects immunocompromised patients and those with underlying lung diseases, such as cystic fibrosis or chronic obstructive pulmonary... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.